Dina Monir Hegab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dina Monir Hegab has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Amany Mohamed Hamed
Chemistry Department, Faculty of Science, Sohag University, Sohag 82524, Egypt
2 shared publications - Azza M. A. Abouelella
Department of Clinical Pharmacology, Faculty of Medicine, Sohag University, Sohag 82524, Egypt
2 shared publications - Elsayed Eldeeb Mehana Hamouda
Department of Pathology, College of Veterinary Medicine, Alexandria University, Alexandria 26571, Egypt
2 shared publications Hoda M. Moghazy
Medical Physiology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
2 shared publicationsMotamed Mahmoud
Animal Behavior and Husbandry Department, Faculty of Veterinary Medicine, Sohag University, Sohag, Egypt
2 shared publications- Safaa S. Soliman
Department of Zoology, Faculty of Science, Minia University, Minia 61519, Egypt
2 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2219-2234
Involvement of the PINK1/PARKIN pathway in enhancing mitochondrial function and mitophagy in reserpine-induced fibromyalgia mice through strength exercise and coenzyme Q10
Purpose: To assess the impact of reserpine-induced fibromyalgia and evaluate the potential effects of resistance exercise or CoQ10 administration on muscle strength, structure, and expression of mitochondrial markers in adult mice. Central to this investigation is an exploration of the molecular mechanisms underlying mitophagy via the PINK1/Parkin pathway. Methods: This study sought to elucidate the Impact of 4 weeks of either climbing exercise or coenzyme Q10 (CoQ10) supplementation (10 mg/kg, administered once daily) on skeletal muscle and mitochondrial functions within a reserpine-induced fibromyalgia (FM) mouse model. Evaluation encompassed the assessment of key mitochondrial markers, including PTEN-induced kinase 1 (PINK1), PARKIN, Mitofusion2, cytochrome c oxidase, citrate synthase, and fibronectin type III domain-containing protein 5 (FNDC5), alongside morphological examinations of the gastrocnemius muscle. Results: Climbing exercise significantly improved fibromyalgia (FM)-like symptoms and enhanced the expression of mitochondrial marker genes in the gastrocnemius muscle. Histological and ultra-structural studies showed nearly normal muscle fiber structure, banding patterns, mitochondria shape and size, and a notable reduction in collagen fibrosis compared to FM. CoQ10 supplementation also improved mitochondrial gene expression but did not significantly affect FNDC gene expression. Ultrastructural analysis revealed mostly normal muscle fibers with regular banding, though some areas showed disturbances with multiple sub-sarcolemmal and interfibrillar mitochondria. Conclusion: This study underscores the efficacy of both resistance exercise and CoQ10 supplementation as viable strategies for improving FM-related symptoms and enhancing mitochondrial function in mice.
- 2 December 2025
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 126 (4) , 2219-2234
Open AccessInvolvement of the PINK1/PARKIN pathway in enhancing mitochondrial function and mitophagy in reserpine-induced fibromyalgia mice through strength exercise and coenzyme Q10
Purpose: To assess the impact of reserpine-induced fibromyalgia and evaluate the potential effects of resistance exercise or CoQ10 administration on muscle strength, structure, and expression of mitochondrial markers in adult mice. Central to this investigation is an exploration of the molecular mechanisms underlying mitophagy via the PINK1/Parkin pathway. Methods: This study sought to elucidate the Impact of 4 weeks of either climbing exercise or coenzyme Q10 (CoQ10) supplementation (10 mg/kg, administered once daily) on skeletal muscle and mitochondrial functions within a reserpine-induced fibromyalgia (FM) mouse model. Evaluation encompassed the assessment of key mitochondrial markers, including PTEN-induced kinase 1 (PINK1), PARKIN, Mitofusion2, cytochrome c oxidase, citrate synthase, and fibronectin type III domain-containing protein 5 (FNDC5), alongside morphological examinations of the gastrocnemius muscle. Results: Climbing exercise significantly improved fibromyalgia (FM)-like symptoms and enhanced the expression of mitochondrial marker genes in the gastrocnemius muscle. Histological and ultra-structural studies showed nearly normal muscle fiber structure, banding patterns, mitochondria shape and size, and a notable reduction in collagen fibrosis compared to FM. CoQ10 supplementation also improved mitochondrial gene expression but did not significantly affect FNDC gene expression. Ultrastructural analysis revealed mostly normal muscle fibers with regular banding, though some areas showed disturbances with multiple sub-sarcolemmal and interfibrillar mitochondria. Conclusion: This study underscores the efficacy of both resistance exercise and CoQ10 supplementation as viable strategies for improving FM-related symptoms and enhancing mitochondrial function in mice.
- 21 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Intermittent Fasting and Caloriec Restriction Ameliorate High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Male Albino Rats: Targeting PPARα and HNF4α Pathways
Background: This study aimed to assess the impacts of a high-fat diet (HFD) on Nonalcoholic fatty liver disease (NAFLD) and intermittent fasting and caloric restriction in an obesity-induced rat model, focusing on peroxisome proliferator-activated receptor alpha (PPARα) and hepatocyte nuclear factor 4α (HNF4α) pathways. Methods: The experiment involved 66 male Wistar rats, were allocated into six groups: Normal Control (NC): Fed normal chow diet for 16 weeks while after 12 weeks of HFD NAFLD Model: followed by four more weeks on HFD to induce NAFLD, NAFLD-ND (Reversal): switched to normal chow for 4 weeks, Time-Restricted Feeding (TRF): normal chow with time-restricted eating (8 p.m. to 8 a.m.) for 4 weeks, Alternate day fasting (ADF): normal chow with alternating 24-hour feeding and water-only fasting for 4 weeks and calorie Restriction (CR): normal chow with 70% of the NC group's diet for 4 weeks. Results: The NAFLD model group had significantly increased BW, visceral fat, liver index, liver enzymes, fasting blood sugar (FBG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), cholesterol, low and very low-density lipoprotein, and lower high-density steatosis, with decreased fatty acid oxidation (FAO) and lipid exportation gene expression. The NAFLD-ND group showed reduced liver index, enzymes, and hepatic vacuolations, but no significant changes in body weight, fat, FBG, insulin, HOMA-IR, or lipids. Conclusions: A normal diet alone reduces liver steatosis in HFD-induced NAFLD but doesn't fully resolve obesity or metabolic issues, while TRF, ADF, and CR, with a normal diet, improve both metabolic health and NAFLD markers.
- 21 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Intermittent Fasting and Caloriec Restriction Ameliorate High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Male Albino Rats: Targeting PPARα and HNF4α Pathways
Background: This study aimed to assess the impacts of a high-fat diet (HFD) on Nonalcoholic fatty liver disease (NAFLD) and intermittent fasting and caloric restriction in an obesity-induced rat model, focusing on peroxisome proliferator-activated receptor alpha (PPARα) and hepatocyte nuclear factor 4α (HNF4α) pathways. Methods: The experiment involved 66 male Wistar rats, were allocated into six groups: Normal Control (NC): Fed normal chow diet for 16 weeks while after 12 weeks of HFD NAFLD Model: followed by four more weeks on HFD to induce NAFLD, NAFLD-ND (Reversal): switched to normal chow for 4 weeks, Time-Restricted Feeding (TRF): normal chow with time-restricted eating (8 p.m. to 8 a.m.) for 4 weeks, Alternate day fasting (ADF): normal chow with alternating 24-hour feeding and water-only fasting for 4 weeks and calorie Restriction (CR): normal chow with 70% of the NC group's diet for 4 weeks. Results: The NAFLD model group had significantly increased BW, visceral fat, liver index, liver enzymes, fasting blood sugar (FBG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), cholesterol, low and very low-density lipoprotein, and lower high-density steatosis, with decreased fatty acid oxidation (FAO) and lipid exportation gene expression. The NAFLD-ND group showed reduced liver index, enzymes, and hepatic vacuolations, but no significant changes in body weight, fat, FBG, insulin, HOMA-IR, or lipids. Conclusions: A normal diet alone reduces liver steatosis in HFD-induced NAFLD but doesn't fully resolve obesity or metabolic issues, while TRF, ADF, and CR, with a normal diet, improve both metabolic health and NAFLD markers.
- Open Access
- 24 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2607
Melittin Nanoparticles Mitigate Glyphosate-Induced Nephrotoxicity via Cytokine Modulation and Bax/Nrf2 Pathways
Background/Objectives: Glyphosate-based herbicides (GBHs) are widely used agrochemicals implicated in nephrotoxicity through mechanisms involving oxidative stress, inflammation, and tissue remodeling. Natural peptides such as melittin possess potent anti-inflammatory and antioxidant properties; however, their therapeutic use is limited by instability and toxicity. Nanotechnology-based encapsulation presents a promising approach to overcoming these challenges. Objective: This study aimed to evaluate the protective effects of melittin-loaded chitosan–TPP nanoparticles (MEL-NPs) against glyphosate-induced nephrotoxicity in rats, with emphasis on oxidative, inflammatory, and apoptotic pathways. Methods: Female Wistar rats were divided into four groups: control, glyphosate (5 mg/kg/day, 25 days), glyphosate + free melittin, and glyphosate + MEL-NPs (40 µg/kg, orally, 3 times/week). Renal function biomarkers, oxidative stress parameters (MDA, GSH, SOD, CAT, NO), cytokines (TNF-α, IL-6), and serum protein/iron indices were assessed. Western blotting (Nrf2, NGAL), histopathology (H&E), and immunohistochemistry (Bax) were performed. Nanoparticles were characterized by TEM, FTIR, and UV–Vis spectroscopy. Results: Glyphosate exposure caused renal dysfunction, including elevated plasma urea and creatinine levels, and reduced creatinine clearance, indicating impaired glomerular filtration efficiency, oxidative stress (↑increased MDA, NO; ↓decreased GSH, SOD), and upregulation of pro-inflammatory cytokines. Histology revealed tubular degeneration and inflammatory infiltration, while NGAL and Bax were strongly induced. Nrf2 expression was elevated as a compensatory response. Free melittin partially ameliorated these alterations, whereas MEL-NPs provided superior protection, restoring renal function, normalizing oxidative balance, reducing NGAL and Bax expression, and preserving renal histoarchitecture. Conclusions: Melittin nanoparticles confer robust renoprotection against glyphosate-induced nephrotoxicity in rats by modulating oxidative stress, suppressing inflammation, and regulating Nrf2/Bax signaling. These findings highlight nano-melittin as a promising therapeutic platform for managing herbicide-related renal disorders.
- 24 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (11) , 2607
Open AccessMelittin Nanoparticles Mitigate Glyphosate-Induced Nephrotoxicity via Cytokine Modulation and Bax/Nrf2 Pathways
Background/Objectives: Glyphosate-based herbicides (GBHs) are widely used agrochemicals implicated in nephrotoxicity through mechanisms involving oxidative stress, inflammation, and tissue remodeling. Natural peptides such as melittin possess potent anti-inflammatory and antioxidant properties; however, their therapeutic use is limited by instability and toxicity. Nanotechnology-based encapsulation presents a promising approach to overcoming these challenges. Objective: This study aimed to evaluate the protective effects of melittin-loaded chitosan–TPP nanoparticles (MEL-NPs) against glyphosate-induced nephrotoxicity in rats, with emphasis on oxidative, inflammatory, and apoptotic pathways. Methods: Female Wistar rats were divided into four groups: control, glyphosate (5 mg/kg/day, 25 days), glyphosate + free melittin, and glyphosate + MEL-NPs (40 µg/kg, orally, 3 times/week). Renal function biomarkers, oxidative stress parameters (MDA, GSH, SOD, CAT, NO), cytokines (TNF-α, IL-6), and serum protein/iron indices were assessed. Western blotting (Nrf2, NGAL), histopathology (H&E), and immunohistochemistry (Bax) were performed. Nanoparticles were characterized by TEM, FTIR, and UV–Vis spectroscopy. Results: Glyphosate exposure caused renal dysfunction, including elevated plasma urea and creatinine levels, and reduced creatinine clearance, indicating impaired glomerular filtration efficiency, oxidative stress (↑increased MDA, NO; ↓decreased GSH, SOD), and upregulation of pro-inflammatory cytokines. Histology revealed tubular degeneration and inflammatory infiltration, while NGAL and Bax were strongly induced. Nrf2 expression was elevated as a compensatory response. Free melittin partially ameliorated these alterations, whereas MEL-NPs provided superior protection, restoring renal function, normalizing oxidative balance, reducing NGAL and Bax expression, and preserving renal histoarchitecture. Conclusions: Melittin nanoparticles confer robust renoprotection against glyphosate-induced nephrotoxicity in rats by modulating oxidative stress, suppressing inflammation, and regulating Nrf2/Bax signaling. These findings highlight nano-melittin as a promising therapeutic platform for managing herbicide-related renal disorders.
- Open Access
- 15 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1732
Novel Benzenesulfonamide Derivatives of 5′-Aminospirotriazolotriazine Exhibit Anti-Inflammatory Activity by Suppressing Pro-Inflammatory Mediators: In Vitro and In Vivo Evaluation Using a Rat Model of Carrageenan-Induced Paw Edema
Background/Objectives: Inflammation is a crucial and complex mechanism that protects the body against infections. In our study, we propose to provide scientific evidence for the anti-inflammatory properties of 1,3,5-triazine derivatives. Methods: Initially, we ensured the safety of the three synthesized derivatives by administering graded doses of up to 2000 mg/kg intraperitoneally in Wistar rats. Thus, the three derivatives were considered generally safe. We also evaluated their ability to reduce carrageenan-induced rat paw edema. Results: Compounds 1, 2, and 3 demonstrated stronger anti-inflammatory activity than indomethacin (10 mg/kg), achieving maximum inhibition at the fourth hour with percentages of 96.31%, 72.08%, and 99.69%, respectively, at a dose of 200 mg/kg, compared to 57.66% for the standard drug. To explore the mechanism, levels of pro-inflammatory cytokines (TNF-α, IL-1α, IL-1β, IL-6, CRP) and oxidative stress markers were measured in paw tissue. All three compounds significantly reduced these markers more effectively than indomethacin and enhanced antioxidant levels (SOD and GSH) beyond those achieved by the standard treatment. Additionally, the compounds reduced COX-1 and COX-2 levels to values comparable to those in the normal (non-inflamed) control group. Conclusions: Compounds 1, 2, and 3 at doses of 200 mg/kg significantly (p < 0.05) inhibited the heat-induced hemolysis of red blood cell (RBC) membranes by 94.6%, 93.9%, and 95.2%, respectively, compared to 94.5% produced by indomethacin. Consequently, we concluded that 1,3,5-triazine derivatives are a safe antioxidant agent with significant anti-inflammatory activity.
- 15 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1732
Open AccessNovel Benzenesulfonamide Derivatives of 5′-Aminospirotriazolotriazine Exhibit Anti-Inflammatory Activity by Suppressing Pro-Inflammatory Mediators: In Vitro and In Vivo Evaluation Using a Rat Model of Carrageenan-Induced Paw Edema
Background/Objectives: Inflammation is a crucial and complex mechanism that protects the body against infections. In our study, we propose to provide scientific evidence for the anti-inflammatory properties of 1,3,5-triazine derivatives. Methods: Initially, we ensured the safety of the three synthesized derivatives by administering graded doses of up to 2000 mg/kg intraperitoneally in Wistar rats. Thus, the three derivatives were considered generally safe. We also evaluated their ability to reduce carrageenan-induced rat paw edema. Results: Compounds 1, 2, and 3 demonstrated stronger anti-inflammatory activity than indomethacin (10 mg/kg), achieving maximum inhibition at the fourth hour with percentages of 96.31%, 72.08%, and 99.69%, respectively, at a dose of 200 mg/kg, compared to 57.66% for the standard drug. To explore the mechanism, levels of pro-inflammatory cytokines (TNF-α, IL-1α, IL-1β, IL-6, CRP) and oxidative stress markers were measured in paw tissue. All three compounds significantly reduced these markers more effectively than indomethacin and enhanced antioxidant levels (SOD and GSH) beyond those achieved by the standard treatment. Additionally, the compounds reduced COX-1 and COX-2 levels to values comparable to those in the normal (non-inflamed) control group. Conclusions: Compounds 1, 2, and 3 at doses of 200 mg/kg significantly (p < 0.05) inhibited the heat-induced hemolysis of red blood cell (RBC) membranes by 94.6%, 93.9%, and 95.2%, respectively, compared to 94.5% produced by indomethacin. Consequently, we concluded that 1,3,5-triazine derivatives are a safe antioxidant agent with significant anti-inflammatory activity.
- Open Access
- 1 April 2020
- Published by Egyptian Knowledge Bank in Sohag Medical Journal
- Vol. 24 (2) , 8-14
Behavioral Evaluation of rotenone model of Parkinson’s disease in male Wistar rats
Introduction: Parkinson’s disease (PD) is a prevalent neurodegenerative disorder in elderly people. The condition is associated with damage to the dopaminergic neurons in the substantia nigra pars compacta, a great decrement of dopamine neurotransmitter in the striatum, and a deficiency of tyrosine hydroxylase; the rate-determining enzyme during dopamine formation. In rats, rotenone has been administered to induce a syndrome that mimics the behavioral and pathophysiological finding of Parkinson's disease.Aim of the work: To evaluate the behavioral aspects of PD in rotenone-treated Wistar rats.Materials and Methods: Rotenone at 2 mg/kg was injected subcutaneously to male adult Wistar rats in the rotenone-treated group once a day for 4 weeks for induction of PD. Open Field test, object recognition test, Rota-rod test, footprint test and forced swim test were performed at the end of induction. Tyrosine hydroxylase levels in the brain were measured.Results: Our data showed deteriorated behavioral aspects after rotenone treatment, with a decrease in exploration and locomotion, impaired motor coordination, asymmetrical impaired gait, increased depressive-like behaviors, reduction in short-term memory and reduction in tyrosine hydroxylase levels. Conclusion: in this study, rotenone subcutaneously at a dose of 2 mg/kg daily for 4 weeks, in adult male Wistar rats, caused the appearance of the motor and the non-motor features of PD with a marked drop-off tyrosine hydroxylase levels in the striatum.
- 1 April 2020
- Published by Egyptian Knowledge Bank in Sohag Medical Journal
- Vol. 24 (2) , 8-14
Open AccessBehavioral Evaluation of rotenone model of Parkinson’s disease in male Wistar rats
Introduction: Parkinson’s disease (PD) is a prevalent neurodegenerative disorder in elderly people. The condition is associated with damage to the dopaminergic neurons in the substantia nigra pars compacta, a great decrement of dopamine neurotransmitter in the striatum, and a deficiency of tyrosine hydroxylase; the rate-determining enzyme during dopamine formation. In rats, rotenone has been administered to induce a syndrome that mimics the behavioral and pathophysiological finding of Parkinson's disease.Aim of the work: To evaluate the behavioral aspects of PD in rotenone-treated Wistar rats.Materials and Methods: Rotenone at 2 mg/kg was injected subcutaneously to male adult Wistar rats in the rotenone-treated group once a day for 4 weeks for induction of PD. Open Field test, object recognition test, Rota-rod test, footprint test and forced swim test were performed at the end of induction. Tyrosine hydroxylase levels in the brain were measured.Results: Our data showed deteriorated behavioral aspects after rotenone treatment, with a decrease in exploration and locomotion, impaired motor coordination, asymmetrical impaired gait, increased depressive-like behaviors, reduction in short-term memory and reduction in tyrosine hydroxylase levels. Conclusion: in this study, rotenone subcutaneously at a dose of 2 mg/kg daily for 4 weeks, in adult male Wistar rats, caused the appearance of the motor and the non-motor features of PD with a marked drop-off tyrosine hydroxylase levels in the striatum.